Is Medtronic’s Cannula Recall and CoreMap Investment Altering The Investment Case For Medtronic (MDT)?
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
CoreMap raises $37m in Medtronic-led financing round
Medtronic leads $37M investment in ablation mapping startup CoreMap
UBS Upgrades Medtronic (MDT)
UBS Upgrades Medtronic to Buy, Raises Price Target to $100
Is Medtronic (MDT) Fairly Valued After Its Pediatric Cannula Recall?
Medtronic (MDT) Completes $650 Million SPR Deal And Launches ViaVerte
Medtronic (MDT) Stock May Be Fairly Valued As Shares Sit Near A 5 Year Low
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
Medtronic continues assembly of industry’s “broadest” pain therapy portfolio
Medtronic (NYSE:MDT): A Value Stock with a Discounted Valuation and Accelerating Growth
Medtronic Earnings Preview: What to Expect
Medtronic (MDT) Unveils Touch Surgery Aide For Real Time AI In Operating Rooms
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
Medtronic to announce financial results for its first quarter of fiscal year 2027
Medtronic completes SPR Therapeutics acquisition
Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad
How Medtronic’s (MDT) Targeted Device Recall and Earnings Beat Have Changed Its Investment Story
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.